Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by AVEO Pharmaceuticals, Inc.

CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVEO
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVEO
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVEO
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVEO
LG Chem Completes Acquisition of AVEO Oncology
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVEO
AVEO Oncology Stockholders Approve Acquisition by LG Chem
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVEO
LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVEO
AVEO Oncology to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 10, 2021
From AVEO Pharmaceuticals, Inc.
Via Business Wire
Tickers AVEO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS